LAC Med Berhad (KLSE:LACMED)
0.845
+0.020 (2.42%)
At close: Apr 28, 2026
LAC Med Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 21.99 | 20.4 | 20.74 | 13.06 |
| Depreciation & Amortization | 1.29 | 0.39 | 0.29 | 0.18 |
| Loss (Gain) From Sale of Assets | -0.02 | - | - | - |
| Asset Writedown & Restructuring Costs | 0 | 0.01 | 0 | - |
| Provision & Write-off of Bad Debts | 0.67 | 0.32 | -2.11 | 1.55 |
| Other Operating Activities | 3.09 | 5.52 | 6.25 | 3.31 |
| Change in Accounts Receivable | -28.29 | 17.63 | -15.07 | -9.63 |
| Change in Inventory | -7.06 | 0.74 | -10.48 | -1.47 |
| Change in Accounts Payable | 10.18 | -10.95 | 17.87 | -11.93 |
| Change in Unearned Revenue | -6.49 | -2.39 | 4.14 | 7.77 |
| Change in Other Net Operating Assets | 5.03 | -1 | 0.98 | 0.02 |
| Operating Cash Flow | 0.38 | 30.67 | 22.61 | 2.87 |
| Operating Cash Flow Growth | -98.77% | 35.64% | 687.29% | - |
| Capital Expenditures | -9.46 | -0.5 | -0.89 | -0.23 |
| Cash Acquisitions | 0.3 | - | - | - |
| Sale (Purchase) of Intangibles | -2.92 | - | - | - |
| Investment in Securities | 8.48 | -10 | - | - |
| Other Investing Activities | 2.23 | 1.7 | -0.35 | 0.5 |
| Investing Cash Flow | -1.37 | -8.8 | -1.25 | 0.27 |
| Short-Term Debt Issued | 65.2 | 49.76 | 58.39 | 58.49 |
| Long-Term Debt Issued | 9.81 | 7.39 | - | - |
| Total Debt Issued | 75.02 | 57.15 | 58.39 | 58.49 |
| Short-Term Debt Repaid | -42.42 | -50.53 | -67.2 | -44.62 |
| Long-Term Debt Repaid | -25.8 | -11.87 | -0.91 | -0.85 |
| Total Debt Repaid | -68.22 | -62.4 | -68.11 | -45.47 |
| Net Debt Issued (Repaid) | 6.8 | -5.25 | -9.73 | 13.02 |
| Issuance of Common Stock | 55.65 | 0 | - | - |
| Common Dividends Paid | -5 | -18.5 | -4 | -3.4 |
| Other Financing Activities | -5.36 | -0.44 | -1.01 | -0.83 |
| Financing Cash Flow | 52.08 | -24.19 | -14.74 | 8.79 |
| Foreign Exchange Rate Adjustments | -0.28 | - | - | - |
| Net Cash Flow | 50.81 | -2.32 | 6.63 | 11.93 |
| Free Cash Flow | -9.09 | 30.17 | 21.72 | 2.65 |
| Free Cash Flow Growth | - | 38.92% | 721.01% | - |
| Free Cash Flow Margin | -4.51% | 16.47% | 14.45% | 2.48% |
| Free Cash Flow Per Share | -0.08 | 15.09 | 10.86 | 1.32 |
| Cash Interest Paid | 0.72 | 0.44 | 1.01 | 0.83 |
| Cash Income Tax Paid | 7.65 | 6.92 | 5.61 | 4.58 |
| Levered Free Cash Flow | -15.53 | 24.46 | 19.92 | - |
| Unlevered Free Cash Flow | -15.05 | 24.77 | 20.56 | - |
| Change in Working Capital | -26.63 | 4.03 | -2.56 | -15.23 |
Source: S&P Capital IQ. Standard template. Financial Sources.